Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Rocephin- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Rocephin – Drug Insight, 2019 highlights the…
DUBLIN–(BUSINESS WIRE)–The “Rocephin- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Rocephin – Drug Insight, 2019 highlights the…
BALLERUP, Denmark & CHENGDU, China–(BUSINESS WIRE)–LEO Pharma A/S and HitGen Inc. are pleased to announce that HitGen and LEO Pharma…
Data presented by MD Anderson demonstrates superiority for NBTXR3 activated by radiation therapy and anti-PD-1 in combination versus the radiation…
-Bringing Innovative Liver-Focused Cell Therapies to Japanese Markets- MONT-SAINT-GUIBERT, Belgium–(BUSINESS WIRE)–Promethera® Biosciences SA (“Promethera®”) and MEDIPAL HOLDINGS CORPORATION (“MEDIPAL”) today…
Clinical trial collaboration agreement leverages NEC’s cutting-edge AI technology and VAXIMM’s novel oral T-cell immunotherapy technology NEC to make an…
Authorization Represents Significant Advancement in the Global Response to Ebola Merck Remains Committed to Working with International Health Partners in…
DUBLIN–(BUSINESS WIRE)–The “Velmetia – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Velmetia – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Epzicom – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Epzicom – Drug Insight, 2019 highlights…
Phase 1 clinical data show that subcutaneous administration of RUC-4 resulted in a potent, rapid, and sustained platelet inhibition effect;…